ANI Pharmaceuticals Q1 2026 Earnings Strong EPS Beat Highlights Operational Strength NRT Q2 2025 Earnings Trust Reports EPS of 020 Shares Gain 064 CGON Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment Nexa Resources Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction BW Q1 2026 Earnings Wide EPS Miss Weighs on Investor Sentiment Diageo DEO Q1 2026 Earnings EPS Misses Estimates as Spirits Demand Softens Globally